Sequence information
Variant position: 255 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 323 The length of the canonical sequence.
Location on the sequence:
MFLKGHETYSYYGPLNLLTF
N VGYHNEHHDFPNIPGKSLPL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MFLKGHETYSYYGPLNLLTFN VGYHNEHHDFPNIPGKSLPL
Mouse MFLKGHETYSYYGPLNLLTFN VGYHNEHHDFPNVPGKNLPM
Rat MFLKGHETYSYYGPLNLLTFN VGYHNEHHDFPNVPGKNLPL
Bovine MFLKGHETYSYYGPLNLLTFN VGYHNEHHDFPNIPGKSLPL
Chicken MFLKGHETYSYYGPLNLLTFN VGYHNEHHDFPNIPGKSLPL
Xenopus tropicalis MFLKGHETYSYYGPLNYLTFN VGYHNEHHDFPSVPGKNLPL
Caenorhabditis elegans VFKKDQETYSYYGPINMVVFN VGYHVEHHDFPYITGSNLPK
Drosophila MFAKGFETYSYYGPLNWITFN VGYHNEHHDFPAVPGSRLPE
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 323
Sphingolipid delta(4)-desaturase DES1
Literature citations
Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy.
Pant D.C.; Dorboz I.; Schluter A.; Fourcade S.; Launay N.; Joya J.; Aguilera-Albesa S.; Yoldi M.E.; Casasnovas C.; Willis M.J.; Ruiz M.; Ville D.; Lesca G.; Siquier-Pernet K.; Desguerre I.; Yan H.; Wang J.; Burmeister M.; Brady L.; Tarnopolsky M.; Cornet C.; Rubbini D.; Terriente J.; James K.N.; Musaev D.; Zaki M.S.; Patterson M.C.; Lanpher B.C.; Klee E.W.; Pinto e Vairo F.; Wohler E.; Sobreira N.L.M.; Cohen J.S.; Maroofian R.; Galehdari H.; Mazaheri N.; Shariati G.; Colleaux L.; Rodriguez D.; Gleeson J.G.; Pujades C.; Fatemi A.; Boespflug-Tanguy O.; Pujol A.;
J. Clin. Invest. 129:1240-1256(2019)
Cited for: FUNCTION; INVOLVEMENT IN HLD18; VARIANTS HLD18 THR-37; 107-TRP--GLU-323 DEL; ASP-113; ARG-132; TRP-133; 173-ARG--GLU-323 DEL; ASP-189; SER-255; 284-TYR--GLU-323 DEL; 293-TRP--GLU-323 DEL AND GLU-323 DEL; CHARACTERIZATION OF VARIANTS HLD18 ASP-113 AND SER-255;
DEGS1 variant causes neurological disorder.
Dolgin V.; Straussberg R.; Xu R.; Mileva I.; Yogev Y.; Khoury R.; Konen O.; Barhum Y.; Zvulunov A.; Mao C.; Birk O.S.;
Eur. J. Hum. Genet. 27:1668-1676(2019)
Cited for: VARIANT HLD18 SER-255; INVOLVEMENT IN HLD18;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.